Evidence map›Paper›PMID 17934737›Full record

ArticlePlant cell reports2008

Application of Arabidopsis AGAMOUS second intron for the engineered ablation of flower development in transgenic tobacco.

Hui-Zhong Wang, Bin Hu, Guan-Ping Chen, Nong-Nong Shi, Yan Zhao, Qi-Cai Yin, Jun-Jun Liu

Abstract read
PubMed Publisher
In one paragraph

Article in Plant cell reports, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. The Artificial PromoterInternational journal of molecular sciences · 2019
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Hui-Zhong WangKey Laboratory of Biochemistry and Molecular Biology, Hangzhou Normal University, Hangzhou 310018, China. whz62@163.com
Bin Hu
Guan-Ping Chen
Nong-Nong Shi
Yan Zhao
Qi-Cai Yin
Jun-Jun Liu
Hangzhou Normal University · CNCanadian Forest Service · CAZhejiang Gongshang University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To explore a new approach to generating reproductive sterility in transgenic plants, the barnase gene from Bacillus amyloliquefaciens was placed under the control of an 1853-bp nucleotide sequence from the 3'end of the second intron of Arabidopsis AGAMOUS and CaMV 35S (-60) minimal promoter [AG-I-35S (-60)::Barnase], and was introduced into tobacco through transformation mediated by Agrobacterium tumefaciens. All AG-I-35S (-60)::Barnase transgenic plants showed normal vegetative growth and 28% of the transgenic lines displayed complete ablation of flowering. Two transgenic lines, Bar-5 and Bar-15, were 98.1 and 98.4% sterile, respectively, as determined by seed production and germination. When controlled by AG-I-35S (-60) chimeric promoter, barnase mRNA was detected in the reproductive tissues of transgenic tobacco plants, but not in vegetative parts. This study presents the first application of an AG intron sequence in the engineered ablation of sexual reproduction in plants. The AG-I-35S (-60)::Barnase construct can be useful in diminishing pollen and seed formation in plants, providing a novel bisexual sterility strategy for interception of transgene escape and has other potentially commercial use for transgenic engineering.

Indexed as

AGAMOUS Protein, ArabidopsisBacterial ProteinsFlowersGene Expression Regulation, PlantIntronsMicroscopy, Electron, ScanningModels, GeneticNicotianaPlants, Genetically ModifiedPollenReverse Transcriptase Polymerase Chain ReactionRibonucleasesRNA, PlantSeedsAGAMOUS Protein, ArabidopsisBacillus amyloliquefaciens ribonucleaseBacterial ProteinsRibonucleasesRNA, Plant

Identifiers

PMID17934737
OpenAlexW2046517207

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.